Author

Y. J. Zhu

Primary ORCID profile (0000-0003-0429-0802 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Y. J. ZhuiD1 paper · Westlake University

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:proteomics· 3 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

T. Guo· 3 shared G. Ruan· 2 shared R. Sun· 2 shared T. Zhu· 2 shared w. ge· 2 shared X. Cai· 2 shared X. Yi· 2 shared A. Christiansen· 1 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

T. Guo

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

DIA-based Proteomics Identifies IDH2 as a Targetable Regulator of Acquired Drug Resistance in Chronic Myeloid Leukemia

w. liu, Y. Sun, w. ge, f. zhang, l. gan, Y. J. Zhu, T. Guo, k. liu

This study identifies IDH2 as a targetable regulator of drug resistance in CML by analyzing proteomic changes in resistant K562 cells.

bioRxiv · Apr 8, 2021Cancer Biology

PulseDIA: in-depth data independent acquisition mass spectrometry using enhanced gas phase fractionation

X. Cai, W. Ge, X. Yi, R. Sun, J. Zhu, C. Lu, P. Sun, T. Zhu, G. Ruan, C. Yuan, S. Liang, M. Lyu, S. Huang, Y. J. Zhu, T. Guo

PulseDIA improves DIA-MS specificity and sensitivity by using gas phase fractionation, achieving higher protein identification rates in cancer proteomics.

bioRxiv · Sep 30, 2019 · PreprintBiochemistry

High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification

Y. J. Zhu, T. Weiss, Q. Zhang, R. Sun, B. Wang, Z. Wu, Q. Zhong, X. Yi, H. Gao, X. Cai, G. Ruan, T. Zhu, C. Xu, S. Lou, X. Yu, , T. Guo

This study develops a proteomic workflow for FFPE tissues to stratify prostate cancer and DLBCL samples, identifying MPO as a prognostic marker and showing FFPE's utility for biomarker discovery.

bioRxiv · Jun 11, 2019Biochemistry